New York, NY -- (SBWIRE) -- 10/25/2013 -- StockMarketIntel.com issues a special report on the following stocks: 3D EYE SOLUTIONS, IN (OTCMKTS:TDEY), Symantec Corporation (NASDAQ:SYMC), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Glu Mobile Inc. (NASDAQ:GLUU)
3D EYE SOLUTIONS, IN (OTCMKTS:TDEY) gained 36.08%, trading on 82.10 million shares, to end the trade at $0.0132. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.0002 and was moved to the maximum level of $0.0136. The stock changed hands in a range of $0.01 to $0.01, bringing its market capitalization to about $2.89 billion.
What was the Moving Force behind TDEY on Bullish Run? Read This Research Report
Symantec Corporation (NASDAQ:SYMC) declined -12.71%, to complete the trading session at $21.49, with a total volume of 44.75 million shares. The stock, on average, trades on a volume of 5.86 million shares. In the past 52 weeks, the share price has not declined below $17.35 and above $27.10. It floated in a range of $20.89 to $22.28 during the last trading session, with a beta value of 0.94. Its market capitalization now moved to about $15.03 billion. Symantec Corporation is a global provider of security, storage, and systems management solutions that help businesses and consumers secure and manage their information. The Company has five operating segments: Consumer, Security and Compliance, Storage and Server Management, Services, and Other.
Is it the Right to Grab SYMC after the Recent Slump? Get Free Trend Analysis Here
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) recorded a fall of -10.06% and was in a range of $3.57-$3.92 before closing at $3.62. The share price hit its 52-week low of $1.49 and $5.95 was the best price. The stock completed the day with a total volume of 10.35 million shares, versus an average volume of 1.24 million shares. ZIOPHARM Oncology, Inc., is a biotechnology company. The Company employs gene expression and control technology to deliver deoxyribonucleic acid (DNA) for the treatment of cancer. The Company's technology employs Intrexon Corporation's RheoSwitch Therapeutic System to turn on and off, and precisely modulate, gene expression at the cancer site in order to improve the therapeutic index.
Will ZIOP Reach the Bottom after Yesterday’s Correction? Find Out Here
Glu Mobile Inc. (NASDAQ:GLUU) added 4.76% yesterday, bringing its market capitalization around $232.77 million. The total number of shares that changed hands during the session was 6.57 million shares, as compared to average trading volume of 3.14 million shares. The share price, after opening at $3.16, made a high of $3.43 and hovered above $3.07 to end the day at $3.30. Glu Mobile Inc. (Glu) designs, markets and sells mobile games. The Company has developed and published a portfolio of action/adventure and casual games designed to appeal to a cross section of the users of smartphones and tablet devices who purchase its games through direct-to-consumer digital storefronts, as well as users of feature phones served by wireless carriers and other distributors.
For How Long GLUU will fight for Profitability? Read This Trend Analysis report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)